{"CDT": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-CDT", "S-CDT S\u00fcsivesik-defitsiitne transferriin"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S\u00fcsivesikdefitsiitne transferriin"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/susivesikdefitsiitne-transferriin-seerumis-s-cdt/", "comment": "S\u00fcsivesikdefitsiitne transferriin seerumis (S-CDT)\nAlkohol on Euroopas tubaka suitsetamise ja k\u00f5rgenenud verer\u00f5hu j\u00e4rel ning d\u00fcslipideemia ja \u00fclekaalu ees olulisuselt kolmas haigestumise ning enneaegse surma riskifaktor. Alkoholi liigtarvitamine on otseselt seotud rohkem kui 60 erineva meditsiinilise seisundiga, sh hepatiit, s\u00fcdame-veresoonkonna- ja neuroloogilised haigused.\n\n"}, "Baso": {"name": "", "rules": {"parameter_name": {"endswith": ["(Basofiilide suhtarv)", "(Basofiilid absoluutarv)", "(Basofiilide arv)"], "startswith": ["%BASO", "B-BASO", "B-Diff-Baso-"], "equals": ["BASO%", "BASO#", "BASO", "BASO# (basofiilide arv)", "BASO% (basofiilide suhtarv)", "#BASO(Basofiilid absoluutarv)", "BASO% Basofiilide suhtarv", "BASO Basofiilide absoluutarv", "#BASO", "baso%", "baso", "basofiilid %", "baso#", "basofiilid", "basofiilid #", "basof.", "Baso%", "Basofiilide abs arv", "Basofiil", "Basofiilide %", "Basofiilid", "B-Diff-Baso-ar", "Basofiili", "Baso#", "Basofiilide abs ar", "Basofiile", "Basofiilseid", "Basofiilide", "%BAS(Basofiilid protsent)", "Basofiilid veres %", "% Basofiilid", "Abs. arv Basofiilid"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "P": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["fosfaat paastuseerumis", "fS-P (fosfaat)", "s,p-fosfaat", "fosfaat", "S- P", "fS-Fosfaat", "fS-P(Fosfaat)", "S-P(Fosfaat seerumis)", "S,P-P", "S-P(Fosfaat)", "fS-(Fosfaat)", "S-P", "fS-P", "S-(Fosfaat seerumis)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Fosfaat seerumis"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/fosfaat-fs-p/", "comment": "Fosfaat (fS-P)\nT\u00e4iskasvanu organismis on ~700 g fosfaati, millest 85% paikneb anorgaanilise fosfaadina luukoes. Veres leidub orgaanilist fosfaati peamiselt rakusiseselt energiarikaste \u00fchendite nagu ATP samuti AMP ning NADP koosseisus. Fosfaat on oluline ka mitmete ens\u00fc\u00fcmide aktiveerumisel.\n\n"}, "LDH": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": ["S-LDH", "S2-LDH"], "equals": ["S,P-LDH", "LDH Laktaadi deh\u00fcdrogenaas seerumis", "S-LDH", "S-LD(Laktaadi deh\u00fcdrogenaas seerumis)", "S-LD(Laktaadi deh\u00fcdrogenaas)", "laktaadi deh\u00fcdrogenaas seerumis", "ldh", "s,p-ldh"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-LDH"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Laktaadi deh\u00fcdrogenaas", "S-LDH"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/alfa-amulaas-fs-amyl/", "comment": "Laktaadi deh\u00fcdrogenaas on rakusisene ens\u00fc\u00fcm, mida leidub k\u00f5igi keharakkude ts\u00fctoplasmas, k\u00f5ige rohkem s\u00fcdame- ja skeletilihastes, er\u00fctrots\u00fc\u00fctides, maksa- ja neerukoes, v\u00e4hem kopsudes, silelihastes ja ajus. Rakusiseselt on ens\u00fc\u00fcmi aktiivsus u 500x suurem kui seerumis.\n\n"}, "MCH": {"name": "", "rules": {"parameter_name": {"endswith": ["B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis) "], "startswith": [], "equals": ["MCH", "MCH pg", "MCH(Keskmine hemoglobiini hulk er\u00fctrots\u00fc\u00fcdis)", "MCH", "MC(Keskmine hemoglobiini hulk er\u00fctrots\u00fc\u00fcdis)", "MCH Keskmine hemoglobiini hulk er\u00fctrots\u00fc\u00fcdis", "3 E-MCH(Keskmine hemoglobiinihulk er\u00fctrots\u00fc\u00fcdis)", "B-MCH", "B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "2 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "E-MCH(Keskmine hemoglobiinihulk er\u00fctrots\u00fc\u00fcdis)", "mch", "MCH (keskm.hemoglobiin er\u00fctrots\u00fc\u00fcdis)", "11 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "B-MC(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "4 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "8 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "7 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "12 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "12 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "1 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "10 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "3 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)", "9 B-MCH(Keskmine hemoglobiini kogus er\u00fctrots\u00fc\u00fcdis)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "IgG": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-AGA IgG", "S-IgG (immuunglobuliin G)", "S-IgG", "S-IgG Immuunglobuliin G seerumis", "S-Ig(Immuunglobuliin G)", "S-IgG(Immuunglobuliin G seerumis)", "S-IgG(Immuunglobuliin G)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Immuunglobuliin G"]}}, "link": "", "comment": "Immuunglobuliinid (Ig) on grupp plasmavalke, mida s\u00fcnteesivad B l\u00fcmfots\u00fc\u00fcdid ja plasmarakud ning mis eristuvad raske ahela t\u00fc\u00fcbi j\u00e4rgi molekulis viide klassi: IgG, IgM, IgA, IgE, IgD. Immuunglobuliinid toimivad antikehadena, tundes \u00e4ra ning sidudes kehav\u00f5\u00f5raid antigeene (bakterid, viirused, toksiinid jt)  ja vahendades antigeenide h\u00e4vitamist. Elektroforegrammil paiknevad immuunglobuliinid peamiselt \u03b3-globuliinide fraktsioonis ja moodustavad tervel inimesel 20- 25% seerumi valkudest. Kui plasmaraku kloon paljuneb kontrollimatult, produtseeritakse \u00fchte monoklonaalset immuunglobuliini  ja selle kontsentratsioon seerumis t\u00f5useb patoloogiliselt.\n\n"}, "MCHC": {"name": "", "rules": {"parameter_name": {"endswith": ["B-MCHC(Keskmine hemoglobiini konsentratsioon er\u00fctrots\u00fc\u00fcdis)", "E-MCHC(Keskmine hemoglobiinikontsentratsioon er\u00fctrots\u00fc\u00fcdis)"], "startswith": [], "equals": ["MCHC", "B-MCHC(Keskmine hemoglobiinikontsentratsioon er\u00fctrots\u00fc\u00fcdis)", "MCHC, g/L", "MCHC Keskmine hemoglobiini kontsentratsioon er\u00fctrots\u00fc\u00fcdis", "E-MCHC(Keskmine hemoglobiinikontsentratsioon er\u00fctrots\u00fc\u00fcdis)", "B-MCHC(Keskmine hemoglobiini konsentratsioon er\ufffdtrots\ufffd\ufffddis)", "B-MCHC", "MCHC (keskm.Hb kontsentratsioon er\u00fctr.-s)", "MCHC(Keskmine hemoglobiini konsentratsioon er\u00fctrots\u00fc\u00fcdis)", "MCHC g/l", "MCHC(MCHC)", "MCHC Keskmine hemoglobiini konsentratsioon er\u00fctrots\u00fc\u00fcdis", "mchc", "MCH(Keskmine hemoglobiini konsentratsioon er\u00fctrots\u00fc\u00fcdis)", "B-MCH(Keskmine hemoglobiini konsentratsioon er\u00fctrots\u00fc\u00fcdis)", "B-MCH(Keskmine hemoglobiini konsentratsioon er\u00fctrots\u00fc\u00fcdis)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "ALP": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-ALP(Aluseline fosfataas)", "S-ALP (Aluseline fosfataas)", "S-ALP (aluseline fosfataas)", "S-ALP 2(Aluseline fosfataas)", "S-ALP", "S2-ALP", "S-ALP 1(Aluseline fosfataas)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": ["Aluseline fosfataas"], "equals": ["Aluseline fosfataas", "ALP - Leelisfosfataas", "aluseline fosfaas", "S,P-ALP", "S-ALP"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/aluseline-fosfataas-s-alp/", "comment": "Aluseline fosfataas\nAlkaalne v\u00f5ib ka olla\nALP-d on leitud k\u00f5ige k\u00f5rgemates kontsentratsioonides maksas, sapiteede epiteelis ja luudes. Maksas sisaldub ALP Kupffer\u2019i rakkudes, mis \u00fcmbritsevad sapikogumise s\u00fcsteemi."}, "Prot": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["\u00dcldvalk", "S-Prot", "S-Pro(Valk seerumis (\u00fcldvalk))", "Valk seerumis", "S-Prot(Valk seerumis (\u00fcldvalk))", "S,P-Prot", "S-Prot(\u00dcldvalk seerumis)", "\u00dcldvalk seerumis", "valk seerumis", "valk seerumis/plasmas", "S-Prot 2(\u00dcldvalk)", "S-Prot (valk)", "S-Prot Valk (elektroforees)", "S-Prot 1(\u00dcldvalk)", "S-Prot 3(\u00dcldvalk)", "S-Prot 4(\u00dcldvalk)", "S-Prot seerumis"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Valk seerumis (\u00fcldvalk)", "Valk seerumis", "Valk seerumis (\u00fcldvalk) (kolorimeetria)", "\u00dcldvalk seerumis"]}}, "link": "", "comment": "Valk"}, "WBC": {"name": "", "rules": {"parameter_name": {"endswith": ["WBC(Leukots\u00fc\u00fcdid t\u00e4isverest)", "WBC(Leukots\u00fc\u00fcdid)"], "startswith": [], "equals": ["WBC", "B-WBC(Leukots\u00fc\u00fcdid)", "WBC(Leukots\u00fc\u00fcdid t\u00e4isverest)", "B-WBC", "WBC (leukots\u00fc\u00fcdid)", "B-WBC(Leukots\u00fc\u00fctide \u00fcldarv)", "WBC(WBC)", "WBC,10^9/L", "WBC Leukots\u00fc\u00fcdid", "B-WBC(Leukots\ufffd\ufffddid)", "wbc", "leukots\u00fc\u00fcdid", "Leukots\u00fc\u00fcdid veres 10E9/l", "WB(Leukots\u00fc\u00fcdid t\u00e4isverest)", "Leukots\u00fc\u00fcdid", "B-WB(Leukots\u00fc\u00fcdid t\u00e4isverest)", "B-WB(Leukots\u00fc\u00fcdid)", "Leukots\u00fc\u00fcdid(Leukots\u00fc\u00fcdid t\u00e4isverest)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["B-WBC"]}}, "link": "", "comment": ""}, "ALAT": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-ALAT(Alaniini aminotransferaas seerumis)", "S-ALAT (alaniini aminotransferaas)", "ALAT", "S-ALAT", "S-ALAT(Alaniini aminotransferaas)", "S-ALAT 2", "S-ALAT 2(Alaniini aminotransferaas)", "S-ALAT 4", "S-ALAT 3(Alaniini aminotransferaas)", "S-ALAT 1(Alaniini aminotransferaas)", "S-ALAT 1", "S-ALAT 3", "S-ALT(Alaniini aminotransferaas)", "S-ALT", "S-AL(Alaniini aminotransferaas)", "Alaniini aminotransferaas", "Alaniini amonitrasferaas", "Alaniini aminotransferaas (GPT)", "S-ALT(Alaniini aminotransferaas seerumis)", "S-ALT(Alaniini aminotransferaas seerumis (temp 37 kraadi))", "S-ALA(Alaniini aminotransferaas)", "alaniini aminotransferaas seerumis", "alat", "s,p-alat", "S-ALA"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-ALAT", "P-ALAT", "S,P-ALAT", "S-ALT"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S-ALAT", "S,P-ALAT", "GPT Alaniini aminotransferaas", "Alaniini aminotransferaas", "Alaniini aminotransferaas seerumis"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/alaniini-aminotransferaas-s-alat/", "comment": "Alaniini aminotransferaas (S-ALAT)\nALAT on p\u00f5hiliselt maksarakkudes, v\u00e4hem neerudes, s\u00fcdames ja skeletilihastes esinev ens\u00fc\u00fcm. Rakkude kahjustus p\u00f5hjustab nimetatud ens\u00fc\u00fcmi vabanemise vereringesse.\n\n"}, "Chol": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-Chol", "S-Chol (kolesterool)", "S-Chol(Kolesterool)", "S-Chol(Kolesterool seerumis)", "S-Chol Kolesterool seerumis", "kolesterool", "kolesterool seerumis", "s,p-kolesterool"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-Chol", "S,P-Chol"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["kolesterool", "S-Chol"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kolesterool-s-chol/", "comment": "Kolesterool (S-Chol)\nKolesterool on pehme vahajas substants, mis esineb organismis lipiidide fraktsioonis. Kolesteroolil on v\u00e4ga t\u00e4htis koht rakumembraanide koostisosana ning hormoonide ja teiste bioaktiivsete ainete koostises. K\u00f5rgetes kontsentratsioonides on kolesterool riskifaktoriks ateroskleroosi ja sellega seotud m\u00fcokardiinfarkti tekkes.\n\n"}, "CK": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-CK (kreatiini kinaas)", "S-CK(Kreatiini kinaas)", "Kreatiini kinaas", "S-CK (kreatiniini kinaas)", "S-CK", "kreatiini kinaas seerumis", "S-C(Kreatiini kinaas)", "S-CK(Kreatiini kinaas seerumis)", "s,p-ck"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S2-CK", "S-CK"]}, "analysis_name": {"endswith": [], "startswith": ["Kreatiini kinaas ", "Kreatiini kinaas"], "equals": ["Kreatiini kinaas seerumis (kineetika)", "S-CK"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kreatiini-kinaas-s-ck/", "comment": "Kreatiini kinaas (S-CK)\nKreatiini kinaas on rakusisene ens\u00fc\u00fcm, mille aktiivsus on suurim v\u00f6\u00f6tlihastes, s\u00fcdamelihases ja ajus. Kreatiini kinaasil on kolm isoens\u00fc\u00fcmi: BB ajus, MM v\u00f6\u00f6tlihastes, MB s\u00fcdamelihases. Tervel inimesel p\u00e4rineb \u00fcle 90% seerumi kreatiini kinaasist skeletilihastest. Kreatiini kinaasi aktiivsus seerumis on t\u00f5usnud k\u00f5ikide lihasd\u00fcstroofiate puhul ning v\u00f5ib olla t\u00f5usnud pikka aega enne haiguse kliinilist avaldumist.\n\n"}, "IgD": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": []}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "RF": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-RF", "fS-RF(Reumatoidfaktor)", "fS-RF", "fS-RF(Reumatoidfaktor kvantitatiivselt)", "fS-RF (reumatoidfaktor)", "Reumatoidfaktor seerumis (lateksaglutinatsioon) U/ml", "S-RF(Reumatoidfaktor)", "S,P-RF", "P-RF", "s,p-reumatoidfaktor", "fS-R(Reumatoidfaktor)", "fS-Reumatoidfaktor", "fS-Reumatoidfakto", "S-R(Reumatoidfaktor)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Reumatoidfaktor", "Reumatoidfaktor seerumis", "Reumatoidfaktor seerumis/plasmas", "reumatoidfaktor", "fS-Reumatoidfaktor", "S,P-Reumatoidfaktor"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/reumatoidfaktor-fs-rf/", "comment": "Reumatoidfaktor (fS-RF)\nReumatoidfaktor on grupp autoantikehi, mis kuuluvad valdavalt IgM-klassi. Reumatoidfaktor moodustab immuunkomplekse normaalse IgG-molekuli Fc fragmendi vastu, aktiveerib komplemendi ning fikseerub kudedesse.\n\n"}, "NRBC": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["NRBC%", "NRBC", "NRBC#", "NRBC% (normoblastide suhtarv)", "B-NRBC%", "B-NRBC#", "nrbc#", "nrbc%", "nrbc"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": "nucleated red blood cells (NRBC)"}, "LCR": {"name": "", "rules": {"parameter_name": {"endswith": ["P-LCR(Trombots\u00fc\u00fctide suurte vormide suhtarv)"], "startswith": [], "equals": ["1 B-P-LCR(Trombots\u00fc\u00fctide suurte vormide suhtarv)", "B-P-LCR", "P-LCR(P-LCR)", "P-LCR", "P-LC(P-LCR)", "PLCR", "P-LCR (trombots.suurte vormide suhtarv)", "P-LCR(Suurte trombots\u00fc\u00fctidearvu suhe trombots\u00fc\u00fctide koguarvusse)", "B-P-LCR(Trombots\ufffd\ufffdtide suurte vormide suhtarv)", "p-lcr"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["P-LCR"]}}, "link": "https://www.ncbi.nlm.nih.gov/pubmed/16295468", "comment": "large cell ratio"}, "MCV": {"name": "", "rules": {"parameter_name": {"endswith": ["B-MCV(Er\u00fctrots\u00fc\u00fctide keskmine maht)", "E-MCV(Er\u00fctrots\u00fc\u00fcdi keskmine maht)"], "startswith": [], "equals": ["MCV Er\u00fctrots\u00fc\u00fctide kesmine ruumala", "MCV", "MCV(Er\u00fctrots\u00fc\u00fcdi keskmine maht)", "12 B-MCV(Er\u00fctrots\u00fc\u00fctide keskmine maht)", "MCV fl", "MCV(MCV)", "E-MCV(Er\u00fctrots\u00fc\u00fcdi keskmine maht)", "B-MCV", "MCV (er\u00fctr.keskm.maht)", "MCV Er\u00fctrots\u00fc\u00fctide keskmine ruumala", "B-MCV(Er\ufffdtrots\ufffd\ufffdtide keskmine maht)", "B-MCV(Er\u00fctrots\u00fc\u00fcdi keskmine maht)", "MCV, fL", "mcv", "MC(Er\u00fctrots\u00fc\u00fcdi keskmine maht)", "E-MC(Er\u00fctrots\u00fc\u00fcdi keskmine maht)", "B-MC(Er\u00fctrots\u00fc\u00fctide keskmine maht)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "GGT": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-GGT", ",P-GGT", "S-GGT (gamma-gl\u00fctam\u00fc\u00fcli transferaas)", "S-GGT(Gamma-Glutam\u00fc\u00fcli transferaas)", "S-GGT(Gamma-Glutam\ufffd\ufffdli transferaas)", "S-GGT(Gamma-glutam\u00fc\u00fcli transferaas)", "S-GGT(Gammaglutam\u00fc\u00fcli transferaas)", "s,p-ggt", "ggt", "S-GG(Gamma-Glutam\u00fc\u00fcli transferaas)", "S-GG(Gammaglutam\u00fc\u00fcli transferaas)", "gammaglutam\u00fc\u00fcli transferaas seerumis"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-GGT", "P-GGT"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S,P-GGT", "S-GGT"]}}, "link": "", "comment": ""}, "Transf": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["fS-Transf (transferriin)", "fS-Transf(Transferriin)", "fS-Transf(Transferriin seerumis)", "S-Transf", "S-sTransf", "fS-Trans(Transferriin)", "fS-TRF(Transferriin seerumis)", "s,p-transferriin", "transferriin", "P-Transf", "S,P-Transf", "Transferiin"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-Transf"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Transferiin", "Transferriin immuunturbidimeetrilisel meetodil", "transferriin"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/transferriin-fs-transf-transferriini-saturatsioon/", "comment": "Transferriin (fS-Transf), transferriini saturatsioon\n\nTransferriin on peamiselt maksas apotransferriinina s\u00fcnteesitav beeta-globuliin, mille \u00fclesandeks on organismis raua transportimine. Transferriin on nn negatiivne \u00e4geda faasi valk \u2013 st tema kontsentratsioon p\u00f5letike korral v\u00e4heneb. Ka transferriini saturatsioon on m\u00f5justatud \u00e4geda faasi reaktsioonist. Normaalselt k\u00fcllastub transferriin rauaga (transferriini saturatsioon) umbes kolmandiku ulatuses. Transferriiniga seotud raud kantakse luu\u00fcdi noortel punavererakkudel asuvate transmembraansete retseptorite abil rakkudesse hemoglobiini s\u00fcnteesiks v\u00f5i deponeerimiseks ferritiinina ja hemosideriinina. Vabanenud apotransferriin siirdub tagasi verre.\n\n"}, "ASO": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-ASO", "S-ASO (antistreptol\u00fcsiin O)", "S,P-ASO", "S-ASO(Antistreptol\u00fcsiin O)", "S-ASO(Antistreptol\u00fcsiin O seerumis)", "S-ASO (antistreptol\u00fcsiin <ANONYM>)", "S-AOS(Antistreptol\u00fcsiin O)", "S-AS(Antistreptol\u00fcsiin O)", "antistreptol\u00fcsiin o seerumis"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-ASO"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Antistreptol\u00fcsiin O seerumis/plasmas", "Antistreptol\u00fcsiin O seerumis", "S-Antistreptol\u00fcsiin O", "antistreptol\u00fcsiin O"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/antistreptolusiin-o-s-aso/", "comment": "Antistreptol\u00fcsiin-O (S-ASO)\nStreptol\u00fcsiinivastased antikehad tekivad organismis A-grupi beeta-hemol\u00fc\u00fctiliste streptokokkide poolt produtseeritud ens\u00fc\u00fcmi streptol\u00fcsiin-O toime neutraliseerimiseks. Nimetatud ens\u00fc\u00fcm p\u00f5hjustab nakatunud organismis er\u00fctrots\u00fc\u00fctide l\u00fc\u00fcsi.\n\n"}, "UA": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-UA (kusihape)", "S-UA", "S-UA(Kusihape seerumis)", "S,P-UA", "S-UA(Kusihape)", "s,p-kusihape", "kusihape", "kusihape seerumis", "S-U(Kusihape)", "S-UricA(Kusihape seerumis)", "Kusihape seerumis", "S-Kusihape 2", "S-Uric(Kusihape seerumis)", "S-Kusihape 1", "S-Kusihape", "S-UricA"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Kusihape", "Kusihape seerumis", "S,P-Kusihape", "S-Kusihape", "Kusihape seerumis (kolorimeetria)"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kusihape-s-ua/", "comment": "Kusihape (S-UA)\n\nKusihape on puriininukleosiidide adenosiini ja guanosiini katabolismi l\u00f5pp-produkt. Umbes 75% kusihappest eritub uriiniga, \u00fclej\u00e4\u00e4nu seedetrakti kaudu.\n\n"}, "IgE": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["IgE", "IgE ( Immuunoglobuliin E)", "S-IgE"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-IgE"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "Bil_conj": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-Bil-conj (bilirubiin konjugeeritud)", "bilirubiin (konjugeeritud)", "s-bilirubiin (konjugeeritud) seerumis", "bilirubiin (konjugeeritud)", "S-Bil-conj", "Bilirubiin, gl\u00fckuroonhappega seotud (direktne bilirubiin, konjugeeritud) \u00b5mol/l", "bilirubiin (konjugeeritud) seerumis", "Bilirubiin (konjugeeritud) (direktne bilirubiin)", "Bilirubiin (konjugeeritud)seerumis/plasmas", "S-Bil-conj(Konjugeeritud bilirubiin seerumis)", "S-Bil-conj(Konjugeeritud bilirubiin)", "S-Bil-conj(Konjugeeritud bilirubiin)", "S-Bil-conj.", "S-Bil-con(Konjugeeritud bilirubiin)", "Bilirubiin, gl\u00fckuroonhappega seotud (direktne bilirubiin)", "S-Bil. direktne", "s,p-bil-direktne", "S-Bil. direktn", "S-Bil-D(Otsene bilirubiin)", "DBil"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-Bil-conj", "S-Bil-D"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Bilirubiin, gl\u00fckuroonhappega seotud (direktne bilirubiin)"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/bilirubiin-fs-bil-konjugeeritud-bilirubiin-fs-bil-conj/", "comment": "konjugeeritud bilirubiin (fS-Bil-conj)\n"}, "Lymph": {"name": "", "rules": {"parameter_name": {"endswith": ["(L\u00fcmfots\u00fc\u00fctide suhtarv)", "Lymph#(L\u00fcmfots\u00fc\u00fctide arv)"], "startswith": ["B-Lymph"], "equals": ["Lymph#", "Lymph%", "LYMPH#", "LYMPH", "B-Diff-LYMPH-arv(L\u00fcmfots\u00fc\u00fctide absoluutarv)", "#LYMPH(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "%LYMPH(L\u00fcmfots\u00fc\u00fcdid protsent)", "B-Diff-LYMPH-%(L\u00fcmfots\u00fc\u00fctide protsent)", "4 B-Diff-LYMPH-%(L\u00fcmfots\u00fc\u00fcdid protsent)", "B-Diff-LYMPH-arv(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "LYMPH%", "LYMPH (abs.)", "B-Diff-LYMPH-%(L\u00fcmfots\u00fc\u00fcdid protsent)", "#LYMPH", "B-Diff-LYMPH-(L\u00fcmfots\u00fc\u00fctide protsent)", "LYMPH% L\u00fcmfots\u00fc\u00fctide suhtarv", "2 B-Diff-LYMPH-%(L\u00fcmfots\u00fc\u00fcdid protsent)", "B-Diff-LYMPH-(L\u00fcmfots\u00fc\u00fcdid protsent)", "2 B-Diff-LYMPH-arv(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "B-LYMPH#", "3 B-Diff-LYMPH-%(L\u00fcmfots\u00fc\u00fcdid protsent)", "1 B-Diff-LYMPH-%(L\u00fcmfots\u00fc\u00fcdid protsent)", "B-LYMPH%", "3 B-Diff-LYMPH-arv(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "B-Diff-LYMPH-ar(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "B-LYMPH", "B-Diff-LYMPH-ar(L\u00fcmfots\u00fc\u00fctide absoluutarv)", "LYMPH L\u00fcmfots\u00fc\u00fctide absoluutarv", "1 B-Diff-LYMPH-arv(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "4 B-Diff-LYMPH-arv(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "lymph#", "lymph%", "lymph", "l\u00fcmfots\u00fc\u00fcdid %", "l\u00fcmfots\u00fc\u00fcdid #", "B-l\u00fcmfots\u00fc\u00fctide (CD19) arv", "l\u00fcmfots\u00fc\u00fcdid", "LYM# (l\u00fcmfots\u00fc\u00fctide arv)", "LYM% (l\u00fcmfots\u00fc\u00fctide suhtarv)", "l\u00fcmfots.", "l\u00fcmfot.", "%LYMP(L\u00fcmfots\u00fc\u00fcdid protsent)", "#LYMP(L\u00fcmfots\u00fc\u00fcdid absoluutarv)", "LYM#", "LYM%", "LYMF L\u00fcmfots\u00fc\u00fcdid", "LYM# (W-SCC)", "LYMP", "LYM% (W-SCR)", "LYM", "LYMF L\u00fcmfots\u00fc\u00fctide suhtarv", "L\u00fcmfots\u00fc\u00fcdid veres %", "% L\u00fcmfots\u00fc\u00fcdid", "L\u00fcmfots\u00fc\u00fcdid", "L\u00fcmfots\u00fc\u00fctide %(L\u00fcmfots\u00fc\u00fcdid protsent)", "L\u00fcmfots\u00fc\u00fcdide abs arv", "L\u00fcmfots\u00fc\u00fcdid %(L\u00fcmfots\u00fc\u00fctide protsent)", "Abs. arv L\u00fcmfots\u00fc\u00fcdid", "L\u00fcmfots\u00fc\u00fcdid(L\u00fcmfots\u00fc\u00fctide absoluutarv)", "L\u00fcmfots\u00fc\u00fcdide abs ar"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["B-Lymph"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["B-Diff-LYMPH-arv"]}}, "link": "", "comment": ""}, "ESR": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["B-ESRw", "B-ESR(Er\u00fctrots\u00fc\u00fctide settekiirus)", "B-ESR", "ESR Er\u00fctrots\u00fc\u00fctide settekiirus", "ESR", "ESR(Er\u00fctrots\u00fc\u00fctide settekiirusPantshenkovi j\u00e4rgi)", "B2-ESRw", "ESR (EDTA)", "ESR (EDTA", "B2-ESR", "Er\u00fctrots\u00fc\u00fctide settekiirus - SR", "Er\u00fctrots\u00fc\u00fctide settekiirus 1(Settekiirus Westergreni j\u00e4rgi)", "B-ES(Er\u00fctrots\u00fc\u00fctide settekiirus)", "Er\u00fctrots\u00fc\u00fctide settekiirus 8(Settekiirus Westergreni j\u00e4rgi)", "B-SR(Er\u00fctrots\u00fc\u00fctide settekiirus Pantshenkovi j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus", "Er\u00fctrots\u00fc\u00fctide settekiirus 2(Settekiirus Westergreni j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus 3(Settekiirus Westergreni j\u00e4rgi)", "er\u00fctrots\u00fc\u00fctide settekiirus statiivil", "Er\u00fctrots\u00fc\u00fctide settekiirus 9(Settekiirus Westergreni j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus 10(Settekiirus Westergreni j\u00e4rgi)", "B-SR(Er\u00fctrots\u00fc\u00fctide settekiirus westergern j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus 7(Settekiirus Westergreni j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus 6(Settekiirus Westergreni j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus(Settekiirus Westergreni j\u00e4rgi)", "Er\u00fctrots\u00fc\u00fctide settekiirus(Optiline (Westergreni m\u00e4\u00e4ramismeetod))", "settekiirus", "Er\u00fctrots\u00fc\u00fctide settekiiru(Settekiirus Westergreni j\u00e4rgi)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["B-ESR", "B-ESRw_", "B-ESRw"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["B-ESRw"]}}, "link": "", "comment": ""}, "LDL": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": ["fS-LDL-Cho"], "equals": ["S-LDL-Chol", "S-LDL -Chol", "S-LDL(Madala tihedusega lipoproteiini kolesterool)", "fS-LDL- Chol", "S-LDL", "fS-LDL(LDL-Kolesterool)", "S-LDL-Chol (LDL kolesterool)", "ldl", "fs,fp-ldl-chol", "s,p-ldl-chol", "ldl-kolesterool paastuseerumis", "S-LD(Madala tihedusega lipoproteiini kolesterool)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-LDL-Chol", "S-LDL", "S.P-LDL-Chol"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S,P-LDL-Chol", "fS,fP-LDL-Chol", "fS-LDL-Chol", "LDL- kolesterool paastuseerumi", "S-LDL"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/ldl-kolesterool-fs-ldl-chol/", "comment": "LDL-kolesterool (fS-LDL-Chol)\nKaks kolmandikku veres ringlevast kolesteroolist on madala tihedusega lipoproteiidide (ingl k low density lipoprotein \u2013 LDL) koosseisus. "}, "RBC": {"name": "", "rules": {"parameter_name": {"endswith": ["B-RBC(Er\u00fctrots\u00fc\u00fcdid veres)", "B-RBC(Er\u00fctrots\u00fc\u00fcdid veres)"], "startswith": [], "equals": ["B-RBC", "RBC", "rbc", "B-RBC(Er\u00fctrots\u00fc\u00fctide \u00fcldarv)", "B-RBC(Er\ufffdtrots\ufffd\ufffddid veres)", "RBC(RBC)", "RBC, 10^12/L", "RBC(Er\u00fctrots\u00fc\u00fcdid veres)", "Er\u00fctrots\u00fc\u00fcdid veres 10E12/l", "Er\u00fctrots\u00fc\u00fcdid(Er\u00fctrots\u00fc\u00fcdid veres)", "B-RB(Er\u00fctrots\u00fc\u00fcdid veres)", "RB(Er\u00fctrots\u00fc\u00fcdid veres)", "RBC Er\u00fctrots\u00fc\u00fcdid", "RBC (er\u00fctrots\u00fc\u00fcdid)", "er\u00fctrots\u00fc\u00fcdid"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["B-RBC"]}}, "link": "", "comment": ""}, "iCa": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-iCa", "S-iCa(Ioniseeritud kaltsium seerumis)", "S-iCa(Ioniseeritud kaltsium)", "B-iCa(Ioniseeritud kaltsium)", "kaltsium (ioniseeritud)", "kaltsium, ioniseeritud, seerumis", "Kaltsium (ioniseeritud)", "S-Ca-Ion", "S-Ca-Io(Kaltsium,ioniseeritud,seerumis)", "S-i Ca", "S-Ca-Ion(Kaltsium,ioniseeritud,seerumis)", "S-iC(Ioniseeritud kaltsium)", "B-iC(Ioniseeritud kaltsium)", "s,p-ica"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-iCa", "S,P-iCa"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S,P-iCa", "Kaltsium, ioniseeritud, seerumis", "Kaltsium (ioniseeritud) seerum"]}}, "link": "", "comment": ""}, "Eo": {"name": "", "rules": {"parameter_name": {"endswith": ["B-Eo%(Eosinofiilide suhtarv)", "(Eosinofiilide arv)", "(Eosinofiilid absoluutarv)", "(eosinofiilide arv)"], "startswith": ["eosinofiilid"], "equals": ["Eo%", "Eosinofiilid", "Eosinofiilide %", "EO% Eosinofiilide suhtarv", "Eosinofiilid veres %", "Eosinofiilseid", "Eosinofiilide", "Eosinofiilide abs arv", "Abs. arv Eosinofiilid", "Eosinofiile", "Eosinofiil", "B-Diff-Eo-arv", "B-Diff-Eo-ar", "B-Diff-Eo-%", "Eo#", "Eosinofiili", "Eosinofiilide abs ar", "% Eosinofiilid", "B-Eo(Eosinofiilide suhtarv)", "%EOS(Eosinofiilid protsent)", "%EO(Eosinofiilid protsent)", "EO Eosinofiilide absoluutarv", "B-Diff-Eo-", "EO% (eosinofiilide suhtarv)", "EO#", "EO", "EO%", "B-EO#", "B-EO%", "EOS", "eo%", "eo#", "eos."]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "Na": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": ["S-Na"], "equals": ["S-Na 3(Naatrium)", "B-N(Naatrium)", "S,P-Na", "Naatrium", "S-N(Naatrium)", "S-N(Naatrium seerumis)", "Naatrium seerumis", "vB-Na", "B-Na(Naatrium)", "Naatrium seerumis (ioonselektiivne) mmol/l", "naatrium", "naatrium seerumis/plasmas", "naatrium seerumis", "s,p-na", "p-na"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Naatrium seerumis", "Naatrium", "Naatrium seerumis/plasmas", "naatrium", "S-Na", "S,P-Na"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/naatrium-s-na/", "comment": "Naatrium (S-Na)\nNaatrium on rakuv\u00e4lise ruumi peamine katioon, mis osaleb vere osmolaalsuse, vee ning happe-aluse tasakaalu regulatsioonis ning neuromuskulaarses erutusjuhtes.\n\n"}, "Cl": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-Cl(Kloriid)", "S-Cl (kloriid)", "B-Cl (kloriid)", "S-Cl(Kloriid seerumis)", "S-Cl", "B-Cl(Kloriid)", "S-Cl(Kloriidid)", "s,p-kloriid", "kloriid seerumis", "S-C(Kloriid)", "Kloriid", "B-C(Kloriid)", "s,p-cl"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kloriid-s-cl/", "comment": "Kloriid (S-Cl)\nKloriid on peamine rakuv\u00e4line anioon, mis koos naatriumiga on k\u00f5ige suurema osmoose aktiivsusega ained plasmas. Kloriidi sisaldus rakkudes on oluliselt v\u00e4iksem kui rakuv\u00e4lises vedelikus (sh vereplasmas).\n\n"}, "Gluc": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": ["fS-Gluc", "B-Gluc", "P-Gluc", "fP-Gluc", "S-Gluc", "cB-Gluc"], "equals": ["B-Gluc", "fS-Gluc(Gl\u00fckoos seerumis)", "fS-Gluc GTT 0 min", "S-Gluc(Gl\u00fckoos seerumis)", "fP-Gluc 0 min (pre)", "fS-Gluc (gl\u00fckoos)", "B-Gluc 6", "fP-Gluc (0 min)", "B-Gluc 4", "P- Gluc", "B-Gluc 11", "S-Gluc", "fB-Gluc", "fP-Gluc GTT 0 min", "P-Gluc", "P-Gluc (120 min)", "B-Gluc 1", "fS-Gluc", "P-Gluc (60 min)", "B1-Gluc", "fS-Gluc 1(Gl\u00fckoos seerumis)", "fP-Gluc (gl\u00fckoos)", "P3-Gluc", "fs-Gluc(Gl\u00fckoos)", "GTT-1h p\u00e4rast gll\u00fckoosi manustamist", "fs,fp-gl\u00fckoos", "gl\u00fckoos", "s,p-gl\u00fckoos", "gl\u00fckoos seerumis", "B-gl\u00fckoos enne koormus", "gl\u00fckoos seerumis/plasmas", "B-gl\u00fckoos enne koormust", "fvs,fvp-gl\u00fckoos", "fs-Glu(Gl\u00fckoos)", "S2-Glu", "S-Glu(Gl\u00fckoos seerumis)", "B-Glu", "S-Glu", "fS-Glu(Gl\u00fckoos seerumis)"]}, "parameter_code": {"endswith": [], "startswith": ["S-GTT", "P-GTT"], "equals": ["fS,fP-Gluc", "P-Gluc-p", "P3-Gluc", "fB-Gluc", "B-Gluc", "S-Gluc", "P-Gluc", "P-GlucTT", "P-GTT-0"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["21.00 Gl\u00fckoos t\u00e4isveres (gl\u00fckomeetriga)", "fs-Gluc", "Gl\u00fckoos seerumis", "S-Gluc", "gl\u00fckoos seerumis/plasmas", "B-gl\u00fckoos enne koormust"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/glukoos-fp-gluc/", "comment": "Gl\u00fckoos (fP-Gluc)\n\nGl\u00fckoos on inimese keha peamine energiaallikas. Seda saadakse toiduga ning gl\u00fckogenol\u00fc\u00fcsi ja gl\u00fckoneogeneesi k\u00e4igus. Gl\u00fckoosi sisaldust veres hoiavad kitsastes piirides stabiilsena hormoonid: insuliin, gl\u00fckagoon, adrenaliin, kortisool ja kasvuhormoon.\n\n"}, "Amyl": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": ["S-Amyl", "P-Amyl"], "equals": ["S,P-Amyl", "am\u00fclaas", "s,p-am\u00fclaas", "S-Amy(Alfa-am\u00fclaas)", "Alfa-am\u00fclaas seerumis", "s,p-alfa-am\u00fclaas", "S-Amy(Am\u00fclaas seerumis)", "S-Am\u00fclaas", "S1-Amy", "S-Amy"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": ["am\u00fclaas", "Am\u00fclaas seerumis"], "equals": ["Am\u00fclaas", "Am\u00fclaas seerumis", "Alfa-am\u00fclaas seerumis", "S,P-Am\u00fclaas", "S-Am\u00fclaas"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/alfa-amulaas-fs-amyl/", "comment": "Am\u00fclaas sekreteeritakse pankrease aatsinuse rakkudest pankrease n\u00f5resse, kus ta duodeenumisse sattudes osaleb t\u00e4rklise seedimises.\n\n"}, "PLT": {"name": "", "rules": {"parameter_name": {"endswith": ["B-PLT(Trombots\u00fc\u00fcdid)", "B-Plt(Trombots\u00fc\u00fctide arv)"], "startswith": [], "equals": ["PLT Trombots\u00fc\u00fcdid", "Trombots\u00fc\u00fcdid", "Trombots\u00fc\u00fcdid 10E9/l", "Trombots\u00fc\u00fcdid (mikroskoopia)", "PLT(Trombots\u00fc\u00fcdid)", "Trombots\u00fc\u00fcdid(Trombots\u00fc\u00fcdid)", "B-PL(Trombots\u00fc\u00fcdid)", "PLT (trombots\u00fc\u00fcdid)", "PLT", "B-PLT", "B-PLT(Trombots\u00fc\u00fctide \u00fcldarv)", "PLT(Trombots\u00fc\u00fctide arv)", "PLT(PLT)", "PLT, 10^3/mL", "plt", "9 B-Plt(Trombots\u00fc\u00fctide arv)", "Plt", "B-Plt(Trombots\ufffd\ufffdtide arv)", "PL(Trombots\u00fc\u00fctide arv)", "B-Pl(Trombots\u00fc\u00fctide arv)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["B-PLT"]}}, "link": "http://r.details.loinc.org/LOINC/777-3.html?sections=Comprehensive", "comment": ""}, "Mono": {"name": "", "rules": {"parameter_name": {"endswith": ["(Monots\u00fc\u00fctide arv)", "B-Mono-arv", "B-Mono-%", "(Monots\u00fc\u00fcdid protsent)", "B-Mono%(Monots\u00fc\u00fctide suhtarv)"], "startswith": ["MONO", "B-MONO", "Monots\u00fc\u00fctide", "Monots\u00fc\u00fc", "Mono#"], "equals": ["%MONO(Monots\u00fc\u00fcdid protsent)", "#MONO(Monots\u00fc\u00fcdid absoluutarv)", "mono%", "monots\u00fc\u00fcdid", "monots.", "mono", "monots\u00fc\u00fcdid %", "mono#", "monots\u00fc\u00fcdid #", "B-Mono%(Monots\ufffd\ufffdtide suhtarv)", "B-Mono-ar", "11 B-Mono%(Monots\u00fc\u00fctide suhtarv)", "B-Diff-Mono-%", "1 B-Mono-arv", "B-Diff-Mono-", "B-Diff-Mono-arv", "10 B-Mono%(Monots\u00fc\u00fctide suhtarv)", "3 B-Mono-%", "#MON(Monots\u00fc\u00fcdid absoluutarv)", "% Monots\u00fc\u00fcdid", "B-Mono#(Monots\ufffd\ufffdtide arv)", "B-Mono%(Monots\u00fc\u00fctide suhtarv)", "B-Mono-", "B-Mono(Monots\u00fc\u00fctide suhtarv)", "Mono%", "Abs. arv Monots\u00fc\u00fcdid", "B-Diff-Mono-ar"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "TSH": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-TSH 1(T\u00fcreotropiin)", "S-TSH", "S,P-TSH", "S-TSH(T\u00fcreotropiin ehk kilpn\u00e4\u00e4ret stimuleeriv hormoon)", "S-TSH 2(T\u00fcreotropiin)", "S2-TSH", "TSH / T\u00fcreotropiin", "S-TSH(T\u00fcreotropiin)", "S-TS(T\u00fcreotropiin)", "S-TS(T\u00fcreotropiin ehk kilpn\u00e4\u00e4ret stimuleeriv hormoon)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-TSH"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["T\u00fcreotropiin", "Kilpn\u00e4\u00e4ret stimuleeriv hormoon seerumis/plasmas", "TSH Kilpn\u00e4\u00e4ret stimuleeriv hormoon plasmas", "TSH T\u00fcreotropiin ehk kilpn\u00e4\u00e4ret stimuleeriv hormoon seerumis", "S,P-TSH", "S-TSH", "T\u00fcreotropiin ehk kilpn\u00e4\u00e4ret stimuleeriv hormoon", "T\u00fcreotropiin ehk kilpn\u00e4\u00e4ret stimuleeriv hormoon seerumis (ELFA)"]}}, "link": "", "comment": ""}, "IgM": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-IgM", "S-IgM (immuunglobuliin M)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-IgM"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Immunoglobuliin M", "Immuunglobuliin M"]}}, "link": "", "comment": ""}, "Trombokrit": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["PCT(Trombokrit)", "PC(Trombokrit)", "Trombokrit", "B-PCT(Trombokrit)", "Trombokritt %", "Trombokrit %", "PCT (trombokrit)", "Trombokri"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": "PCT, aga segamini aetav Prokaltsitoniiniga (PCT)"}, "Neut": {"name": "", "rules": {"parameter_name": {"endswith": ["%(Neutrofiilide suhtarv)", "(Neutrofiilide arv)"], "startswith": ["%NEUT"], "equals": ["Neutrofiilide %", "2 B-Neut%(Neutrofiilide suhtarv)", "9 B-Neut%(Neutrofiilide suhtarv)", "Neut%", "Neutrofiilide abs arv", "Neutrofiilide", "Neutrofiilide abs ar", "%NEU(Neutrofiilide protsent, kepptuumsed ja segmenttuumsed.)", "% Neutrofiilid", "#NEUT(Neutrofiilid absoluut arv, kepptuumsed ja segmenttuumsed)", "B-Diff-NEUT-arv(Neutrofiilide absoluut arv)", "Abs. arv Neutrofiilid", "#NEU(Neutrofiilid absoluut arv, kepptuumsed ja segmenttuumsed)", "Neut#", "B-Neut(Neutrofiilide suhtarv)", "B-Diff-NEUT-%(Neutrofiilide protsent)", "B-Diff-NEUT-(Neutrofiilide protsent)", "NEUT% Neutrofiilide suhtarv", "NEUT Neutrofiilide absoluutarv", "B-Diff-NEUT-ar(Neutrofiilide absoluut arv)", "NEUT# (neutrofiilide arv)", "NEUT#", "NEUT%", "B-NEUT%", "NEUT%(neutrofiilide suhtarv)", "NEUT", "B-NEUT#", "NEUT% (W-LCR)", "NEUT# (W-LCC)", "neut%", "neutrofiilid %", "neutrofiilid", "neut#", "neutrofiilid #", "neut"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "Crea": {"name": "", "rules": {"parameter_name": {"endswith": ["-Crea", "(Kreatiniin)", "CreaC"], "startswith": ["fS-Crea", "fS-Crea", "S-Crea"], "equals": ["Kreatiniin seerumis", "s,p-kreatiniin", "kreatiniin seerumis/plasmas"]}, "parameter_code": {"endswith": ["(kreatiniin)"], "startswith": ["S-Crea", "S2-Crea"], "equals": []}, "analysis_name": {"endswith": ["S-Crea"], "startswith": [], "equals": ["Kreatiniin seerumis/plasmas", "Kreatiniin seerumis", "Kreatiniin paastuseerumis", "Kreatiniin paastuseerumis", "S,P-Kreatiniin"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kreatiniin-s-crea/", "comment": "Kreatiniin (S-Crea)\nKreatiniin moodustub lihaskoes lihaskontraktsiooni metaboolse protsessi k\u00e4igus kreatiinist ning eritub organismist peamiselt neerude kaudu. Tekkiva kreatiniini hulk on suhteliselt stabiilne ja otseselt seotud lihasmassiga.\n\n"}, "K": {"name": "", "rules": {"parameter_name": {"endswith": ["Kaalium seerumis", "Kaalium seerumis)"], "startswith": ["S-K "], "equals": ["S-K ", "S-K ", "S-K\t", "S-K", "S-K(Kaalium)", "kaalium seerumis/plasmas", "kaalium seerumis", "kaalium", "Kaalium", "B-K(Kaalium)", "vB-K", "S-(Kaalium)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": ["Kaalium seerumis"], "equals": ["Kaalium seerumis", "kaalium", "Kaalium", "S-K"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kaalium-s-k/", "comment": "Kaalium on peamine rakusisene katioon, mis osaleb lihaste, s\u00fcdame, neerude ja keskn\u00e4rvis\u00fcsteemi ainevahetuses, m\u00e4\u00e4rab sile- ja v\u00f6\u00f6tlihaste toonuse, toimib neuromuskulaarses erutusjuhtes.\n\n"}, "Ca": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["fS-Ca", "S-Ca", "fS-Ca (kaltsium)", "S-Ca(Kaltsium)", "S-Ca 3(Kaltsium)", "kaltsium", "kaltsium seerumis/plasmas", "kaltsium seerumis", "S-C(Kaltsium)", "S-C(Kaltsium seerumis)", "S-Ca 2(Kaltsium)", "S-Ca(Kaltsium seerumis)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S,P-Ca", "S-Ca"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S,P-Ca", "Katsium seerumis", "Kaltsium seerumis", "Kaltsium paastuseerumis"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/kaltsium-s-ca-ioniseeritud-kaltsium-fs-ica/", "comment": "Kaltsium (S-Ca)"}, "Bil": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-Bil-T(Bilirubiin seerumis)", "S-Bil 2(Bilirubiin \u00fcldine)", "S-Bil", "S-Bil(Bilirubiin \ufffdldine)", "S-Bil(Bilirubiin)", "S-Bil 2(Bilirubiin)", "Bilirubiin, \u00fcldine", "S-Bil 3(Bilirubiin \u00fcldine)", "S-Bil(Bilirubiin, \u00fcldine)", "S-Bi(Bilirubiin, \u00fcldine)", "S-Bi(Bilirubiin \u00fcldine)", "S,P-Bil", "TBil", "S-Bi(Bilirubiin)", "S-Bil 1(Bilirubiin)", "S-Bil 1(Bilirubiin \u00fcldine)", "S-Bil(Bilirubiin \u00fcldine)", "S-Bil 4(Bilirubiin \u00fcldine)", "P-Bil", "S-Bil(\u00dcldbilirubiin)", "S-Bil (bilirubiin)", "S-Bil."]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-Bil", "S,P-Bil"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Bilirubiin seerumis"]}}, "link": "", "comment": ""}, "INR": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["INR", "S-INR", "Protrombiini aeg", "Protrombiini aktiivsuseprotsent", "P-INR 1(Protrombiini kompleks)", "P-PT-INR - Protrombiini aeg- rahvusvaheline normitud suhe", "P-INR(Protrombiini kompleks)", "P-PT-INR 3(Protrombiini aeg; INR)", "P-INR 3(Protrombiini kompleks)", "P-PT-IN(Protrombiini aeg; INR)", "P-PT-INR 1(Protrombiini aeg; INR)", "P-PT-INR(Protrombiini aeg; INR)", "P-PT-INR 2(Protrombiini aeg; INR)", "INR (teraap.piir 2-3)", "P-PT-INR 6(Protrombiini aeg; INR)", "P-PT-INR 7(Protrombiini aeg; INR)", "P-PT-INR 4(Protrombiini aeg; INR)", "P-INR 4(Protrombiini kompleks)", "P2-PT-INR", "P-INR 2(Protrombiini kompleks)", "Protrombiini aktiivsus", "INR (teraap.pii", "P-PT-INR 9(Protrombiini aeg; INR)", "P-PTs - Protrombiini aeg sekundites"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["P-PT-INR"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["INR - Protrombiini indeks", "Protrombiini indeks", "P-PT-INR", "P-PT/INR", "Protrombiini indeks (INR)", "Protrombiini aeg", "Protrombiini aeg plasmas", "Protrombiini aeg plasmas"]}}, "link": "", "comment": ""}, "RDW": {"name": "", "rules": {"parameter_name": {"endswith": ["RDW(Er\u00fctrots\u00fc\u00fctide suurusjaotuvus)"], "startswith": [], "equals": ["B-RDW(Er\u00fctrots\u00fc\u00fctide suurusjaotuvus)", "rdw", "RDW", "3 RDW%", "RDW %", "RDW%", "1 RDW%", "B-RDW(Er\ufffdtrots\ufffd\ufffdtide suurusjaotuvus)", "4 RDW%", "rdw-cv", "rdw-sd", "RDW-CV", "RDW-SD", "RDW-SD (er\u00fctrots\u00fc\u00fctide suurusjaotuvus)", "RDWa", "RDW Er\u00fctrots\u00fc\u00fctide anisots\u00fctoosi n\u00e4itaja", "RDW-CV(Er\u00fctrots\u00fc\u00fctide suurusjaotuvuse variatsioonikoefitsent)", "B-RDW-CV", "RDW-CV (er\u00fctrots\u00fc\u00fctide suurusjaotuvus)", "RDW-CW", "RDW-C", "RDW-S", "RDW-S", "RDW-CD", "RDW, CV", "RDW, CV", "RDWR", "RDW-C(Er\u00fctrots\u00fc\u00fctide suurusjaotuvuse variatsioonikoefitsent)", "2 RDW%", "RDW- CV", "RDW-CV Er\u00fctrots\u00fc\u00fctide anisots\u00fctoosi n\u00e4itaja", "RDW(Er\u00fctrots\u00fc\u00fctide suurusjaotuvuse (varjatsioonikoehvitsent))", "RD(Er\u00fctrots\u00fc\u00fctide suurusjaotuvuse (varjatsioonikoehvitsent))", "B-RD(Er\u00fctrots\u00fc\u00fctide suurusjaotuvus)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "Urea": {"name": "", "rules": {"parameter_name": {"endswith": ["(Uurea seerumis)"], "startswith": ["fS-Urea", "S-Urea"], "equals": ["s,p-uurea", "fs-Urea 2(Uurea)", "fs-Urea 1(Uurea)", "uurea paastuseerumis/paastuplasmas", "uurea", "Uurea seerumis", "fs-Urea(Uurea)", "fS-Ure(Uurea)", "fs-Ure(Uurea)", "uurea paastuseerumis", "fs-Urea 3(Uurea)", "S2-Ure", "S-Ure"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": ["Uurea"], "equals": ["Uurea seerumis", "Uurea seerumis/plasmas", "Uurea seerumis (kolorimeetria)", "S,P-Uurea", "Urea", "S-Urea", "fs-Urea"]}}, "link": "", "comment": ""}, "HbA1c": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["B-HbA1c", "B-HbA1c-IFC( uue \u00fchikuga)", "2 B-HbA1c-IFCC(HbA1c uue \u00fchikuga)", "HbA1c %", "B-HbA1c (gl\u00fckohemoglobiin)", "Hemoglobiin, gl\u00fckeeritud, A1C suhe", "B-HbA1c-IFCC( uue \u00fchikuga)", "B-HbA1c-IFC", "B-HbA1c-IFCC", "B-HbA1c-IFC(HbA1c uue \u00fchikuga)", "B-HbA1c-IFCC(HbA1c uue \u00fchikuga)", "b-hba1c (ifcc)", "hba1c (ifcc)", "B-HbA1C", "B-HbA1(Gl\u00fckeeritud hemoglobiini fraktsioon A1c)", "1 B-HbA1C(Gl\u00fckeeritud hemoglobiini fraktsioon A1c)", "2 B-HbA1C(Gl\u00fckeeritud hemoglobiini fraktsioon A1c)", "B-HbA1C(Gl\u00fckeeritud hemoglobiini fraktsioon A1c)", "Gl\u00fckeeritud hemoglobiin, A1C fraktsioon %", "Gl\u00fckeeritud hemoglobiin, A1C fraktsioon", "B-HbA1C(Gl\u00fckeeritud hemoglobiin (turbidimeetria+fotomeetria))", "Gl\u00fckeeritud hemoglobiin A1C fraktsioon"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["B-HbA1c", "B-HbA1C"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Gl\u00fckeeritud hemoglobiini fraktsioon", "B-HbA1c-IFCC", "B-HbA1c", "B-HbA1c (IFCC)", "Gl\u00fckeeritud hemoglobiin A1C fraktsioon", "Hemoglobiin, gl\u00fckeeritud, A1C fraktsioon", "Hemoglobiin, gl\u00fckeeritud A1C suhe"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/glukohemoglobiin-b-hba1c/", "comment": "Gl\u00fckohemoglobiin (B-HbA1c)\nGl\u00fckohemoglobiin moodustub gl\u00fckoosij\u00e4\u00e4gi mitteens\u00fcmaatilisel seostumisel hemoglobiini aminor\u00fchmaga. HbA1c on p\u00f5hifraktsioon, mis moodustab ligikaudu 80% kogu gl\u00fckeeritud hemoglobiinist HbA1.\n\n"}, "Ret": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["B-Ret(Retikulots\u00fc\u00fctide arv)", "Retikulots\u00fc\u00fcdid", "Retikulots\u00fc\u00fcdi", "Retikulots.%", "B-Ret(Retikolots\u00fc\u00fctide suhtarv)", "B-Ret#(Retikulots\u00fc\u00fctide arv)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "HDL": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-HDL-Chol (HDL kolesterool)", "fS-HDL-Chol(HDL-kolesterool seerumis)", "fS-HDL-Chol", "S-HDL", "S-HDL-Chol(HDL kolesterool)", "fS-HDL(HDL-Kolesterool)", "S-HDL-Chol", "fS-HDL-Cho", "S-HDL(K\u00f5rge tihedusega lipoproteiini kolesterool)", "fS-HDL-Chol(HDL-Kolesterool)", "fS-HDL-Cho(HDL-Kolesterool)", "hdl", "s,p-hdl-chol", "fs,fp-hdl-chol", "hdl-kolesterool paastuseerumis", "S-HD(K\u00f5rge tihedusega lipoproteiini kolesterool)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-HDL", "S-HDL-Chol"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["S-HDL", "HDL-kolesterool seerumis/plasmas", "fS-HDL-Chol", "S,P-HDL-Chol", "HDL- kolesterool paastuseerumi", "fS,fP-HDL-Chol", "K\u00f5rge tihedusega lipoproteiini kolesterool"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/hdl-kolesterool-fs-hdl-chol/", "comment": "HDL-kolesterool (fS-HDL-Chol)\nSuure tihedusega lipoproteiinide ehk HDL (ingl k High density lipoprotein \u2013 HDL) koosseisus transporditakse kolesterool kudedest maksa.\n\n"}, "CRP": {"name": "", "rules": {"parameter_name": {"endswith": ["C-reaktiivne valk veres"], "startswith": ["S-CRP", "C-reaktiivne valk"], "equals": ["C-reaktiivne valk", "S1-CRP", "S-CR(C-reaktiivne valk seerumis)", "c-reaktiivne valk seerumis", "c-reaktiivne valk seerumis/plasmas", "S-CR(C-reaktiivne valk)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["P-CRP"]}, "analysis_name": {"endswith": [], "startswith": ["C-reaktiivne valk", "S,P-CRP"], "equals": ["CRP C-reaktiivne valk", "S-CRP", "CRP", "CRP - C-reaktiivne valk"]}}, "link": "", "comment": "C-reaktiivne valk\n\nS-hsCRP(K\u00f5rgtundlik C-reaktiivne valk)  \t (m\u00f5\u00f5tmismeetod erinev)"}, "PDW": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["PDW", "PDW(Trombots\u00fc\u00fctide jaotuvus mahuj\u00e4rgi. e. trombots\u00fc\u00fctide anisots\u00fctoosim\u00e4\u00e4r)", "PDW %", "PDW Trombots\u00fc\u00fctide anisots\u00fctoosi n\u00e4itaja", "4 PDW(Trombots\u00fc\u00fctide jaotuvus mahuj\u00e4rgi. e. trombots\u00fc\u00fctide anisots\u00fctoosim\u00e4\u00e4r)", "PDW (trombots\u00fc\u00fctide suurusjaotuvus)", "1 PDW(Trombots\u00fc\u00fctide jaotuvus mahuj\u00e4rgi. e. trombots\u00fc\u00fctide anisots\u00fctoosim\u00e4\u00e4r)", "3 PDW(Trombots\u00fc\u00fctide jaotuvus mahuj\u00e4rgi. e. trombots\u00fc\u00fctide anisots\u00fctoosim\u00e4\u00e4r)", "2 PDW(Trombots\u00fc\u00fctide jaotuvus mahuj\u00e4rgi. e. trombots\u00fc\u00fctide anisots\u00fctoosim\u00e4\u00e4r)", "pdw", "PD(Trombots\u00fc\u00fctide jaotuvus mahuj\u00e4rgi. e. trombots\u00fc\u00fctide anisots\u00fctoosim\u00e4\u00e4r)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "http://r.details.loinc.org/LOINC/32207-3.html?sections=Comprehensive", "comment": "Platelet distribution width"}, "MPV": {"name": "", "rules": {"parameter_name": {"endswith": ["MPV(Trombots\u00fc\u00fctide keskmine maht)"], "startswith": [], "equals": ["B-MPV", "MPV", "3 MPV(Trombots\u00fc\u00fctide keskmine maht)", "MPV Trombots\u00fc\u00fctide keskmine maht", "MPV (trombots.keskmine maht)", "MPV fl", "MPV, fL", "B-MPV(Trombots\ufffd\ufffdtide keskmine maht)", "B-MP(Trombots\u00fc\u00fctide keskmine maht)", "MP(Trombots\u00fc\u00fctide keskmine maht)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "IgA": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-IgA (immuunglobuliin A)", "S-IgA(Immuunglobuliin A seerumis)", "S-IgA"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S,P-IgA", "S-IgA"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Immuunoglobuliin A", "Immuunglobuliin A seerumis", "Immoglobuliin A"]}}, "link": "", "comment": ""}, "Trigl": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["fS-Trigl(Trigl\u00fctseriidid seerumis)", "fS-Trigl", "fS-Trigl (trigl\u00fctseriidid)", "fS-Trig", "fS-Trig(Trigl\u00fctseriidid)", "fS-Trigl(Trigl\u00fctseriidid)\t", "fS-Trigl(Trigl\u00fctseriidid)", "S-Trigl(Trigl\u00fctseriidid)", "S-Trig", "S2-Trig", "S-Trig(Trigl\u00fctseriidid)", "S-Trigl(Trigl\u00fctseriidid seerumis)", "S-Trigl", "S-Trigl.", "trigl\u00fctseriidid", "fs,fp-trigl\u00fctseriidid", "trigl\u00fctseriidid paastuseerumis"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["fS-Trig", "Trigl\u00fctseriidid seerumis (kolorimeetria)", "Trigl\u00fctseriidid", "Trigl\u00fctseriidid seerumis", "Trigl\u00fctseriidid paastuseerumis", "fS,fP-Trigl\u00fctseriidid", "Trigl\u00fctseriidid paastuseerumis/paastuplasmas", "S-Trigl"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/triglutseriidid-fs-trig/", "comment": "Trigl\u00fctseriidid on oluline energia varuallikas organismis. Kui vereringes on trigl\u00fctseriidide liig, deponeeritakse osa neist rasvkoesse.\n\n"}, "Alb": {"name": "", "rules": {"parameter_name": {"endswith": ["Albumiin seerumis)"], "startswith": ["S-Alb"], "equals": ["S-Alb (albumiin)", "Albumiin", "S-Alb", "S-Alb(Albumiin)", "S-Al(Albumiin)", "albumiin seerumis/plasmas", "s,p-albumiin", "albumiin seerumis", "albumiin", "S-alb", "S-alb"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": ["Albumiin"], "equals": ["Alb - Albumiin seerumis"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/albumiin-s-alb/", "comment": "Albumiin on plasmas k\u00f5ige suuremas koguses esinev valk, moodustades plasma valkude massist umbes poole.\n\n"}, "PCT": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["prokaltsitoniin", "S-PCT (prokaltsitoniin)", "S-PCT(Prokaltsitoniin)", "S- PCT(Prokaltsitoniin)", "S- PC(Prokaltsitoniin)", "S-PC(Prokaltsitoniin)", "s,p-prokaltsitoniin"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Prokaltsitoniin seerumis", "Prokaltsitoniin", "Prokaltsitoniin plasmas"]}}, "link": "https://labtestsonline.org/understanding/analytes/procalcitonin/tab/test/", "comment": "procalcitonin test is "}, "Fe": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["fS-Fe", "S-Fe(Raud)", "S-Fe", "fS-Fe (raud)", "fS-Fe(Raud)", "raud", "raud seerumis", "s,p-fe", "S-F(Raud)", "fS-F(Raud)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Raud", "Raud seerumis", "Raud seerumis/plasmas", "raud"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/raud-fs-fe/", "comment": "Raud (fS-Fe)\n70% organismis leiduvast rauast on hemoglobiini koosseisus, \u00fclej\u00e4\u00e4nud 30% on deponeeritud ferritiini ja hemosideriinina.\n\nToiduga saadud rauast imendub umbes 10% peensooles ning transporditakse kandurvalgu transferriiniga seotult luu\u00fcdisse.\n\n"}, "HCT": {"name": "", "rules": {"parameter_name": {"endswith": ["B-Hct(Hematokrit)"], "startswith": [], "equals": ["HCT", "HCT Hematokritt", "HCT (Q)", "HCT(HCT)", "HCT (hematokrit)", "B-HCT", "HCT(Hematokrit)", "HC(Hematokrit)", "Hematokrit", "Hematokrit(Hematokritt)", "B-Hc(Hematokritt)", "3 B-Hct(Hematokritt)", "Hematokri", "B-Hc(Hematokrit)", "B-Hct(Hematokritt)", "Hematokritt %", "Hematokrit %", "4 B-Hct(Hematokritt)", "2 B-Hct(Hematokritt)", "1 B-Hct(Hematokritt)", "hct", "b-hct", "Hct"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["B-Hct"]}}, "link": "", "comment": "Hematokrit"}, "HGB": {"name": "", "rules": {"parameter_name": {"endswith": ["(Hemoglobiin veres)"], "startswith": [], "equals": ["HGB", "HGB Hemoglobiin", "HGB(Hemoglobiin veres)", "HGB (hemoglobiin)", "HGB(HGB)", "B-HGB", "HGB, g/L", "3 B-Hb(Hemoglobiin veres)", "HG(Hemoglobiin veres)", "12 B-Hb(Hemoglobiin veres)", "B-Hb(Hemoglobiini kontsentratsioon)", "B-H(Hemoglobiini kontsentratsioon)", "2 B-Hb(Hemoglobiin veres)", "3 B-Hgb(Hemoglobiin veres)", "Hemoglobiin", "1 B-Hgb(Hemoglobiin veres)", "B-Hg(Hemoglobiin veres)", "B-Hgb(Hemoglobiini kontsentratsioon)", "4 B-Hgb(Hemoglobiin veres)", "9 B-Hb(Hemoglobiin veres)", "8 B-Hb(Hemoglobiin veres)", "B-Hb(Hemoglobiin veres)", "Hemoglobiin veres g/l", "Hb", "hgb"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": ""}, "ASAT": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-ASAT 3", "S-ASAT", "S-ASAT (aspartaadi aminotransferaas)", "S-ASAT 1", "P-ASAT", "S-ASAT(Aspartaadi aminotransferaas)", "S-ASAT 4", "S-ASAT 2(Aspartaadi aminotransferaas)", "S-ASAT(Aspartaadi aminotransferaas seerumis)", "S-ASAT 2", "S-ASAT 1(Aspartaadi aminotransferaas)", "S-ASAT 3(Aspartaadi aminotransferaas)", "s,p-asat", "asat", "Aspartaadi aminotransferaas (GOT)", "S-AST(Aspartaadi transaminaas)", "S-AST(Aspartaadi aminotransferaas)", "S-AS(Aspartaadi aminotransferaas)", "S-ASA(Aspartaadi aminotransferaas)", "S-AST(Aspartaadi aminotransferaas seerumis (temp 37 C))", "Aspartaadi aminotransferaas seerumis (kineetika) U/l", "S-AST(Aspartaadi aminotransferaas seerumis)", "aspartaadi aminotransferaas seerumis", "S-AST", "S-AST", "S-ASA"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Aspartaadi aminotransferaas seerumis/plasmas", "S,P-ASAT", "S-ASAT", "Aspartaadi aminotransferaas", "ASAT Aspartaadi aminotransferaas seerumis", "GOT - Aspartaadi aminotransferaas", "Aspartaadi aminotransferaas (GOT)", "S-AST"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/aspartaadi-aminotransferaas-s-asat/", "comment": "Aspartaadi aminotransferaas (S-ASAT)\nASAT on ens\u00fc\u00fcm, mida v\u00f5ib leida v\u00e4ga suurtes kontsentratsioonides intensiivse metabolismiga kudedes nagu s\u00fcdamelihas, maksarakud, skeletilihased ning v\u00e4iksemates kogustes neerudes, pankreases ja er\u00fctrots\u00fc\u00fctides.\n\n"}, "Mg": {"name": "", "rules": {"parameter_name": {"endswith": [], "startswith": [], "equals": ["S-Mg", "S-Mg (magneesium)", "S-Mg(Magneesium seerumis)", "S-Mg(Magneesium)", "Magneesium seerumis (kolorimeetria) mmol/l", "S,P-Mg", "magneesium", "s,p-magneesium", "magneesium seerumis/plasmas", "magneesium seerumis", "S-M(Magneesium)", "S-M(Magneesium seerumis)", "s,p-mg"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": ["S-Mg(magneesium)", "S-Mg", "S,P-Mg"]}, "analysis_name": {"endswith": [], "startswith": [], "equals": ["Magneesium seerumis"]}}, "link": "http://synlab.ee/arstile/laboriteatmik/tulemuste-interpretatsioonid/kliinilise-keemia-uuringud/magneesium-fs-mg/", "comment": "Magneesium (fS-Mg)\nT\u00e4iskasvanu organism sisaldab ~ 25 g magneesiumit.\n\nMagneesium on rakusisene katioon, millest 55% asub luukoes, 20% lihastes, 19% mujal kudedes ja 1% ekstratsellulaarses vedelikus.\n\n"}, "IG": {"name": "", "rules": {"parameter_name": {"endswith": ["Ebak\u00fcpsete granulots\u00fc\u00fctide arv)"], "startswith": [], "equals": ["IG - Ebak\u00fcpsed granulots\u00fc\u00fcdid", "IG% - Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv", "IG%", "9 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG%(Percentage of immature granulocytes (% of WBC))", "IG - Ebak\u00fcpsete granulots\u00fc\u00fctide arv", "IG% - Ebak\u00fcps.granulots\u00fc\u00fctide %", "B-IG#(Ebak\ufffdpsete granulots\ufffd\ufffdtide arv)", "8 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG#", "7 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "B-IG%(Ebak\ufffdpsete granulots\ufffd\ufffdtide suhtarv)", "IG Ebak\u00fcpsete granulots\u00fc\u00fcdide absoluutarv", "11 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG#(Immature granulocyte concentration)", "12 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG# Ebak\u00fcpsed granulots\u00fc\u00fcdid", "3 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG(Immature granulocyte concentration)", "IG(Percentage of immature granulocytes (% of WBC))", "B-IG(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG% Ebak\u00fcpsete granulots\u00fc\u00fcdide suhtarv", "2 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "IG% Ebak\u00fcpsed granulots\u00fc\u00fcdid suhtarv", "10 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "1 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)", "4 B-IG%(Ebak\u00fcpsete granulots\u00fc\u00fctide suhtarv)"]}, "parameter_code": {"endswith": [], "startswith": [], "equals": []}, "analysis_name": {"endswith": [], "startswith": [], "equals": []}}, "link": "", "comment": "Ebak\u00fcpsed granulots\u00fc\u00fcdid"}}